April 28, 2021

$ADMA ADMA Biologics Stock Up On FDA Approval for Increased IVIG Production Scale

ADMA stock rose in early trading on April 28, 2021, after the company announced that it has received FDA approval for increased IVIG production. ADMA Biologics, Inc., an end-to-end commercial biopharmaceutical

Stock Trading

March 28, 2021

$OPK Rockefeller Foundation Pushing COVID-19 School Testing Program

OPK stock could see a substantial increase over the coming months as globalist groups like the Rockefeller Foundation are pushing a COVID-19 testing and vaccination tracking program onto schools, students,

Stock Trading

March 15, 2021

$CHEK Check-Cap Stock Soars On FDA Study Approval

CHEK stock soared more than 100% in pre-market trading on March 15, 2021, after the company announced FDA approval to study its technology. Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK),

Biotechnology

March 9, 2021

$ANPC AnPac Bio-Medical Science Evaluates New Cancer Detection Sensor

ANPC stock rose in pre-market trading on new cancer detection sensor. AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in China and

Stock Trading

February 25, 2021

$SRTS Sensus Healthcare Stock Surges 37% In After-hours On Beats

SRTS stock exploded 37% higher in after-hours trading on February 25, 2021, after the company reported earnings and revenue beats. Sensus Healthcare reports Q4 EPS of 6c versus the consensus estimate

Stock Trading

February 17, 2021

$AHAC Alpha Healthcare Acquisition Up On Humacyte Merge

AHAC stock rose higher in early trading on February 17, 2021, after the company announced a going public merger with Humacyte. Alpha Healthcare Acquisition Corp. (Nasdaq: AHAC) (“AHAC”), a special purpose

Stock Trading

February 16, 2021

$PAVM PAVmed Stock Explodes Higher On First Patient Success

PAVM stock exploded higher on February 16, 2021, after the company announced that the first U.S. patient recently underwent successful carpal tunnel release using its CarpX® minimally invasive carpal tunnel device. PAVmed Inc. (Nasdaq: PAVM,

Biotechnology

February 16, 2021

$SESN Sesen Bio Stock Soars In Pre-market On FDA Priority Review

SESN stock rose more than 9% in pre-market trading on February 16, 2021, after the company announced that it has received priority review from the FDA for its Vicineum. Sesen Bio

Marijuana Stocks

Options Trading

February 15, 2021

$XXII 22nd Century Stock Higher On Hopes Biden To Legalize Weed

All pot stocks rallied last week on hopes that corporations will have their Democrats legalize pot. President Biden and Democrats have indicated they aim to decriminalize the drug at the

Biotechnology

February 11, 2021

$MNPR Monopar Therapeutics Soars 55% In Pre-market

MNPR stock soared more than 55% in pre-market trading on February 11, 2021, after the company announced the publication of a peer-reviewed study in the European Journal of Cancer which

« Older Articles